- Product Details
Keywords
- fasoracetam
- nootropics
- 110958-19-5
Quick Details
- ProName: fasoracetam
- CasNo: 110958-19-5
- Molecular Formula: C10H16 N2 O2
- Application: pharmaceutical
- ProductionCapacity: Metric Ton/Day
- Purity: 99%
- LimitNum: 0 Metric Ton
Superiority
Fasoracetam // Cas:110958-19-5//Neuroprotective effect
Basic information:
Fasoracetam
Cas 110958-19-5
Chemcila name 2-Pyrrolidinone,5-(1-piperidinylcarbonyl)-, (5R)-
Synonym Piperidine,1-[(5-oxo-2-pyrrolidinyl)carbonyl]-, (R)-; Piperidine,1-[[(2R)-5-oxo-2-pyrrolidinyl]carbonyl]- (9CI); Fasoracetam; NS 105; NS 105(pharmaceutical)
MF C10H16 N2 O2
MW 196.25
Density:
1.181g/cm3
Boiling Point:
456.8°Cat760mmHg
Flash Point:
230.1°C
Details
Description:
Fasoracetam (a.k.a. NS-105 and LAM-105) is a potent HACU-inhibiting, cAMP-modulating, GABAB receptor upregulating/antagonizing, mGluR-modulating, non-monoaminergic anti-depressant nootropic.
It has been trialled for Alzheimer's Disease, but failed to meet expectations in efficacy for this particular indication in clinical trials. It is now being investigated for applications in ADHD, particularly as a genome-specific therapy in patients with mGluR mutations.